Preoperative Cognitive Screening of Elderly Surgical Patients
NCT01826825 is an observational study sponsored by Brigham and Women's Hospital. As of 18 Nov 2026, it is completed. It studies Cognitive Impairment. The registry lists an enrollment of 200 participants at 1 site in 1 country. The registry lists a start date of 31 May 2013 and a primary completion date of 31 Oct 2013.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT01826825 |
| Status | Completed |
| Study type | Observational study |
| Lead sponsor | Brigham and Women's Hospital |
| Enrollment | 200 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Cognitive Impairment |
| Start | 31 May 2013 |
| Primary completion | 31 Oct 2013 |
| Study completion | 31 Aug 2015 |
| Last update posted | 14 Apr 2021 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Angela Bader, MD, MPH
Brigham and Women's Hospital
Study Chair - Deborah J Culley, MD
Brigham Hospital
Principal Investigator - Devon M Flaherty, MD, MPH
Brigham and Women's Hospital
Study Director - James Rudolph, MD
Brigham Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Brigham and Women's Hospital
Boston
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT01826825
Each answer restates registry values shown on this page.
What is NCT01826825?
NCT01826825 is an observational study sponsored by Brigham and Women's Hospital. It studies Cognitive Impairment.
Who leads NCT01826825?
The registry names Angela Bader, MD, MPH (study chair, Brigham and Women's Hospital), Deborah J Culley, MD (principal investigator, Brigham Hospital), Devon M Flaherty, MD, MPH (study director, Brigham and Women's Hospital) and 1 more official as overall officials.
Where does NCT01826825 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT01826825 end?
The registry lists a primary completion date of 31 Oct 2013 and a study completion date of 31 Aug 2015. The sponsor last updated the record on 14 Apr 2021.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.